CompletedPhase 2NCT01372449

A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)

Studying Infantile neuroaxonal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Evdokia Anagnostou
Principal Investigator
Evdokia Anagnostou, M.D.
Holland Bloorview Kids Rehabilitation Hospital
Intervention
Memantine(drug)
Enrollment
23 enrolled
Eligibility
6-12 years · All sexes
Timeline
20112015

Study locations (2)

Collaborators

Icahn School of Medicine at Mount Sinai · Rush University Medical Center · Nationwide Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01372449 on ClinicalTrials.gov

Other trials for Infantile neuroaxonal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Infantile neuroaxonal dystrophy

← Back to all trials